Table 2 Distribution of individual items at the third day of intravenous corticosteroid (IVCS) therapy
Day 3 variableIVCS response (n = 53)IVCS failure (n = 46)Odds ratio (95% CI)*
Nocturnal diarrhoea (episodes/per night)20.6 (4.9 to 87)
    None25 (47%)2 (4%)
    1–228 (53%)30 (65%)
    >20 (0%)14 (31%)
Stools per 24 h4.2 (4.3 to 7.7)
    0–222 (42%)4 (9%)
    3–525 (47%)14 (30%)
    6–85 (9%)14 (30%)
    >81 (2%)14 (30%)
Blood in stool3.5 (1.8 to 7.1)
    None or small amount infrequently10 (19%)2 (4%)
    Small amount in majority of stools24 (45%)10 (22%)
    Large amount in the majority of stools19 (36%)34 (74%)
Temperature (>37.8°C)***4 (8%)9 (20%)2.9 (0.8 to 10.4)
Abdominal tenderness†6 (11%)11 (24%)2.5 (0.8 to 7.3)
PUCAI score50 (SD 17)70 (SD 14)2.2 (1.5 to 3.1)**
Seo score194 (SD 34)226 (SD 30)1.4 (1.2 to 1.6)**
Lindgren score4.2 (SD 2.3)9.4 (SD 4.3)1.6 (1.3 to 1.9)
Travis score
    Positive0 (0%)17 (38%)31 (3.9 to 666)
    Negative53 (100%)29 (62%)
Blood tests
    Albumin33 (SD 5.7)30 (SD 4.4)0.53 (0.4 to 0.8)††
    CRP (mg/dl)0.71 (SD 0.53)1.87 (SD 1.57)6.2 (2.6 to 14.9)
    ESR38 (SD 22)50 (SD 25)1.3 (1.03 to 1.5)**
    Haemoglobin (g/l)101 (SD 22)97 (SD 17)1 (0.97 to 1.01)
    Platelets (×109/litre) 452 (SD 142)496 (SD 158)1 (0.99 to 1.01)**
  • Count (%), median (interquartile range) or mean (SD) are presented as appropriate for the data distribution.

  • *Obtained by an unadjusted logistic regression, without dummy variables.

  • **Calculated for a 10-unit change.

  • ***Temperature was measured orally.

  • †Judged as at least mild tenderness by the physician.

  • ††Calculated for a 5-unit change.

  • PUCAI, Pediatric Ulcerative Colitis Activity Index; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.